FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1810160594> ?p ?o ?g. }

• W1810160594 endingPage "351" @default.
• W1810160594 startingPage "348" @default.
• W1810160594 abstract "Abstract Isolated limb infusion (ILI) was developed as a simplified and minimally invasive alternative to isolated limb perfusion (ILP) to treat unresectable limb melanoma. A number of centers around the world have reported their results using this procedure. In this study a systematic review of reported ILI experiences was undertaken. A literature search was conducted according to the guidelines for systematic reviews in order to select eligible papers reporting limb toxicity and response rates following ILI using melphalan and actinomycin D to treat limb melanoma. A total of 576 patients from seven publications were included. Regional toxicity following ILI was low: no visible effect of the treatment or slight erythema or edema was observed in 79% of the patients, while considerable erythema and/or edema with blistering was experienced by 19%. In 2% there was a threatened or actual compartment syndrome. No procedure‐related amputation was reported. Complete response occurred in 33% of the patients and partial response in 40%, an overall response rate of 73%. Stable disease and progressive disease were achieved in 14% and 13% of the patients, respectively. This first systematic review of ILI procedures using melphalan and actinomycin D indicates that regional toxicity was generally low, with satisfactory response rates. When comparing ILI and ILP, it must be borne in mind that ILI is often performed in significantly older patients and in patients with higher stages of disease, which decreases the likelihood of a favorable response. J. Surg. Oncol. 2014 109:348–351 . © 2014 Wiley Periodicals, Inc." @default.
• W1810160594 created "2016-06-24" @default.
• W1810160594 creator A5010897664 @default.
• W1810160594 creator A5033283703 @default.
• W1810160594 creator A5035263718 @default.
• W1810160594 creator A5068945269 @default.
• W1810160594 date "2014-02-12" @default.
• W1810160594 modified "2023-10-05" @default.
• W1810160594 title "Isolated limb infusion with melphalan and actinomycin D for melanoma: A systematic review" @default.
• W1810160594 cites W141961275 @default.
• W1810160594 cites W1574206311 @default.
• W1810160594 cites W1639979835 @default.
• W1810160594 cites W1966913821 @default.
• W1810160594 cites W1973593314 @default.
• W1810160594 cites W1985020677 @default.
• W1810160594 cites W1985784022 @default.
• W1810160594 cites W1998402899 @default.
• W1810160594 cites W2007984865 @default.
• W1810160594 cites W2019262025 @default.
• W1810160594 cites W2020871746 @default.
• W1810160594 cites W2021347851 @default.
• W1810160594 cites W2023011617 @default.
• W1810160594 cites W2025195895 @default.
• W1810160594 cites W2025810400 @default.
• W1810160594 cites W2028699294 @default.
• W1810160594 cites W2037546201 @default.
• W1810160594 cites W2049903029 @default.
• W1810160594 cites W2053096632 @default.
• W1810160594 cites W2054378153 @default.
• W1810160594 cites W2069426891 @default.
• W1810160594 cites W2072088428 @default.
• W1810160594 cites W2079406854 @default.
• W1810160594 cites W2087676114 @default.
• W1810160594 cites W2097995306 @default.
• W1810160594 cites W2106543129 @default.
• W1810160594 cites W2120507692 @default.
• W1810160594 cites W2123785252 @default.
• W1810160594 cites W2143455014 @default.
• W1810160594 cites W2144340025 @default.
• W1810160594 cites W4229709118 @default.
• W1810160594 doi "https://doi.org/10.1002/jso.23553" @default.
• W1810160594 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24522939" @default.
• W1810160594 hasPublicationYear "2014" @default.
• W1810160594 type Work @default.
• W1810160594 sameAs 1810160594 @default.
• W1810160594 citedByCount "51" @default.
• W1810160594 countsByYear W18101605942014 @default.
• W1810160594 countsByYear W18101605942015 @default.
• W1810160594 countsByYear W18101605942016 @default.
• W1810160594 countsByYear W18101605942017 @default.
• W1810160594 countsByYear W18101605942018 @default.
• W1810160594 countsByYear W18101605942019 @default.
• W1810160594 countsByYear W18101605942020 @default.
• W1810160594 countsByYear W18101605942021 @default.
• W1810160594 countsByYear W18101605942022 @default.
• W1810160594 countsByYear W18101605942023 @default.
• W1810160594 crossrefType "journal-article" @default.
• W1810160594 hasAuthorship W1810160594A5010897664 @default.
• W1810160594 hasAuthorship W1810160594A5033283703 @default.
• W1810160594 hasAuthorship W1810160594A5035263718 @default.
• W1810160594 hasAuthorship W1810160594A5068945269 @default.
• W1810160594 hasConcept C126322002 @default.
• W1810160594 hasConcept C141071460 @default.
• W1810160594 hasConcept C146957229 @default.
• W1810160594 hasConcept C16005928 @default.
• W1810160594 hasConcept C2776204877 @default.
• W1810160594 hasConcept C2776694085 @default.
• W1810160594 hasConcept C2777658100 @default.
• W1810160594 hasConcept C2778684742 @default.
• W1810160594 hasConcept C2779121184 @default.
• W1810160594 hasConcept C2780886150 @default.
• W1810160594 hasConcept C29730261 @default.
• W1810160594 hasConcept C502942594 @default.
• W1810160594 hasConcept C71924100 @default.
• W1810160594 hasConceptScore W1810160594C126322002 @default.
• W1810160594 hasConceptScore W1810160594C141071460 @default.
• W1810160594 hasConceptScore W1810160594C146957229 @default.
• W1810160594 hasConceptScore W1810160594C16005928 @default.
• W1810160594 hasConceptScore W1810160594C2776204877 @default.
• W1810160594 hasConceptScore W1810160594C2776694085 @default.
• W1810160594 hasConceptScore W1810160594C2777658100 @default.
• W1810160594 hasConceptScore W1810160594C2778684742 @default.
• W1810160594 hasConceptScore W1810160594C2779121184 @default.
• W1810160594 hasConceptScore W1810160594C2780886150 @default.
• W1810160594 hasConceptScore W1810160594C29730261 @default.
• W1810160594 hasConceptScore W1810160594C502942594 @default.
• W1810160594 hasConceptScore W1810160594C71924100 @default.
• W1810160594 hasIssue "4" @default.
• W1810160594 hasLocation W18101605941 @default.
• W1810160594 hasLocation W18101605942 @default.
• W1810160594 hasOpenAccess W1810160594 @default.
• W1810160594 hasPrimaryLocation W18101605941 @default.
• W1810160594 hasRelatedWork W1969505757 @default.
• W1810160594 hasRelatedWork W1998068602 @default.
• W1810160594 hasRelatedWork W2002231196 @default.
• W1810160594 hasRelatedWork W2030938964 @default.
• W1810160594 hasRelatedWork W2033479047 @default.
• W1810160594 hasRelatedWork W2086094746 @default.

• next